Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics ; volume:20 ; number:1 ; day:28 ; month:1 ; year:2020 ; pages:1-11 ; date:12.2020
Cancer cell international ; 20, Heft 1 (28.1.2020), 1-11, 12.2020
- Urheber
-
Zweiri, Jehad
Christmas, Stephen E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-020-1115-4
- URN
-
urn:nbn:de:101:1-2020042703384607137653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zweiri, Jehad
- Christmas, Stephen E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
Acid affairs in anti-tumour immunity
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Glutarate regulates T cell metabolism and anti-tumour immunity
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer